ArticleScientific reports2026

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study.

Harun Muğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.